Akari Therapeutics, Plc (AKTX)

Akari Therapeutics, Statistics

Total Valuation

AKTX has a market cap or net worth of $12.90 million. The enterprise value is $12.63 million.

Market Cap	12.90M
Enterprise Value	12.63M

Important Dates

The last earnings date was Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

AKTX has 45.78 million shares outstanding. The number of shares has increased by 238.34% in one year.

Current Share Class	n/a
Shares Outstanding	45.78M
Shares Change (YoY)	+238.34%
Shares Change (QoQ)	+3.78%
Owned by Insiders (%)	57.62%
Owned by Institutions (%)	2.70%
Float	18.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.40
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.19, with a Debt / Equity ratio of 0.10.

Current Ratio	0.19
Quick Ratio	0.16
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-37.61

Financial Efficiency

Return on equity (ROE) is -197.24% and return on invested capital (ROIC) is -85.65%.

Return on Equity (ROE)	-197.24%
Return on Assets (ROA)	-34.20%
Return on Invested Capital (ROIC)	-85.65%
Return on Capital Employed (ROCE)	-44.16%
Revenue Per Employee	n/a
Profits Per Employee	-$1.75M
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.09M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -77.99% in the last 52 weeks. The beta is 0.28, so AKTX's price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	-77.99%
50-Day Moving Average	0.43
200-Day Moving Average	0.92
Relative Strength Index (RSI)	37.91
Average Volume (20 Days)	1,592,844

Short Selling Information

Short Interest	519,225
Short Previous Month	69,172
Short % of Shares Out	0.67%
Short % of Float	n/a
Short Ratio (days to cover)	1.21

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-13.16M
Pretax Income	-16.86M
Net Income	-15.77M
EBITDA	-13.15M
EBIT	-13.16M
Earnings Per Share (EPS)	-$0.57

Balance Sheet

The company has $2.48 million in cash and $2.22 million in debt, with a net cash position of $267,000 or $0.01 per share.

Cash & Cash Equivalents	2.48M
Total Debt	2.22M
Net Cash	267,000
Net Cash Per Share	$0.01
Equity (Book Value)	22.69M
Book Value Per Share	0.70
Working Capital	-12.62M

Cash Flow

Operating Cash Flow	-9.65M
Capital Expenditures	n/a
Free Cash Flow	-9.65M
FCF Per Share	-$0.21

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AKTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-238.34%
Shareholder Yield	-238.34%
Earnings Yield	-122.29%
FCF Yield	-74.83%

Analyst Forecast

The average price target for AKTX is $2.53, which is 798.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.53
Price Target Difference	798.12%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 17, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Aug 17, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	1